Unilever Oral Care, Quarry Road East, Bebington, Wirral, CH63 3JW, UK.
Birmingham Dental Hospital and School of Dentistry, 5 Mill Pool Way, Birmingham, B5 7EG, UK.
J Dent. 2019 Jan;80 Suppl 1:S33-S39. doi: 10.1016/j.jdent.2018.11.005.
To compare the clinical effect of toothpastes containing Steareth 30 and SLS (sodium lauryl sulphate) surfactants on oral epithelial integrity (desquamation) using a new Oral Mucosal Sloughing Index (OMSI).
30 volunteers participated in a single centre, double-blind, randomised, crossover clinical study. After a lead-in, subjects were allocated to the first test toothpaste, which was applied to the maxilla via a cap splint, followed by whole mouth brushing with the respective toothpaste and rinsing with the toothpaste slurry. Soft desquamation (lesion status) was assessed using a novel Oral Mucosal Sloughing Index (OMSI). Soft tissue status was measured at baseline (prior to test product use), 30 min following test product application and 4 days later following "at home" use of test toothpaste. After a wash out period, soft tissue assessment and product use were repeated for the remaining toothpaste.
Using the OMSI, 30 min post-application, significantly fewer lesion counts (all sites) were observed for the Steareth 30 toothpaste compared to SLS toothpaste (p < 0.0001). Additionally, 30 min after toothpaste use, the average lesion severity score was significantly lower for the Steareth 30 toothpaste compared to SLS toothpaste (p < 0.0001). There were no significant differences in lesion status at baseline or following 4 days of "at home" use of the toothpastes. No product related adverse events were reported.
Using an Oral Mucosal Sloughing Index for assessment, application of a toothpaste containing Steareth 30 generated significantly less transient soft tissue desquamation (fewer lesion counts and lower severity) than a toothpaste containing SLS.
Treatment with a toothpaste containing Steareth 30 surfactant generated fewer transient soft tissue lesions (lower desquamation) compared to a toothpaste containing SLS surfactant.
使用新的口腔黏膜脱落指数(OMSI)比较含有 Steareth 30 和 SLS(月桂基硫酸钠)表面活性剂的牙膏对口腔上皮完整性(脱皮)的临床效果。
30 名志愿者参加了一项单中心、双盲、随机、交叉临床试验。在导入期后,受试者被分配到第一个测试牙膏,通过帽夹板应用于上颌,然后用各自的牙膏进行全口刷牙并用牙膏浆漱口。使用新型口腔黏膜脱落指数(OMSI)评估软脱落(病变状态)。在使用测试产品之前(基线)、使用测试产品 30 分钟后以及使用测试牙膏“在家”后 4 天测量软组织状态。在洗脱期后,重复使用剩余牙膏进行软组织评估和产品使用。
使用 OMSI,应用后 30 分钟,Steareth 30 牙膏的病变计数(所有部位)明显少于 SLS 牙膏(p<0.0001)。此外,使用牙膏后 30 分钟,Steareth 30 牙膏的平均病变严重程度评分明显低于 SLS 牙膏(p<0.0001)。基线或使用牙膏“在家”4 天后,病变状态无显着差异。未报告与产品相关的不良事件。
使用口腔黏膜脱落指数进行评估,使用含有 Steareth 30 的牙膏可显著减少短暂性软组织脱落(病变计数较少且严重程度较低),而使用含有 SLS 的牙膏则不然。
与含有 SLS 表面活性剂的牙膏相比,使用含有 Steareth 30 表面活性剂的牙膏治疗可产生更少的短暂性软组织病变(较低的脱落)。